The DOI matches its Crossref record; 359 of the 359 references it cites were found in a registry or an index.
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
Open accessAbstract
MicroRNA (miRNA or miR) therapeutics in cancer are based on targeting or mimicking miRNAs involved in cancer onset, progression, angiogenesis, epithelial-mesenchymal transition and metastasis. Several studies conclusively have demonstrated that miRNAs are deeply involved in tumor onset and progression, either behaving as tumor-promoting miRNAs (oncomiRNAs and metastamiRNAs) or as tumor suppressor miRNAs. This review focuses on the most promising examples potentially leading to the development of anticancer, miRNA-based therapeutic protocols. The inhibition of miRNA activity can be readily achieved by the use of miRNA inhibitors and oligomers, including RNA, DNA and DNA analogues (miRNA antisense therapy), small molecule inhibitors, miRNA sponges or through miRNA masking. On the contrary, the enhancement of miRNA function (miRNA replacement therapy) can be achieved by the use of modified miRNA mimetics, such as plasmid or lentiviral vectors carrying miRNA sequences. Combination strategies have been recently developed based on the observation that i) the combined administration of different antagomiR molecules induces greater antitumor effects and ii) some anti-miR molecules can sensitize drug-resistant tumor cell lines to therapeutic drugs. In this review, we discuss two additional issues: i) the combination of miRNA replacement therapy with drug administration and ii) the combination of antagomiR and miRNA replacement therapy. One of the solid results emerging from different independent studies is that miRNA replacement therapy can enhance the antitumor effects of the antitumor drugs. The second important conclusion of the reviewed studies is that the combination of anti-miRNA and miRNA replacement strategies may lead to excellent results, in terms of antitumor effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Items 201–359 of 359
Kang, W., TONG, J. H. M., Lung, R. W. M., Dong, Y., Zhao, J., Liang, Q., Zhang, L., Pan, Y., Yang, W., Pang, J. C. S., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0323-3 · Cited by 129
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
Orellana, E. A., & Kasinski, A. L. (2015) · Cancers · doi:10.3390/cancers7030842 · Cited by 128
MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
Tu, K., Liu, Z., Yao, B., Han, S., & Yang, W. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3309 · Cited by 128
EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1
Chang, Y.-S., Chen, W., Yin, J. J., Sheppard, H., Huang, J., & Liu, Y. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3380 · Cited by 127
Li, L., Li, X., Zhang, X., Lv, Z., He, G., Zhao, W., Ren, X., Li, Y., Bian, X., Liao, W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.11.033 · Cited by 126
microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma
Ling, N., Gu, J., Lei, Z., Li, M., Zhao, J., Zhang, H., & Li, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2685 · Cited by 125
miR-20a triggers metastasis of gallbladder carcinoma
Chang, Y., Liu, C., Yang, J., Liu, G., Feng, F., Tang, J. P., Hu, L., Li, L., Jiang, F., Chen, C., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.034 · Cited by 125
The proto-oncogene Pim-1 is a target of miR-33a
Thomas, M., Lange‐Grünweller, K., Weirauch, U., Gutsch, D., Aigner, A. M., Grünweller, A., & Hartmann, R. K. (2011) · Oncogene · doi:10.1038/onc.2011.278 · Cited by 125
Mechanisms and role of microRNA deregulation in cancer onset and progression
Palmero, E. I., Campos, S. G. P., Campos, M., Nogueira-de-Souza, N. C., Guerreiro, I. D. C., Carvalho, A. L., & Marques, M. M. C. (2011) · Genetics and Molecular Biology · doi:10.1590/s1415-47572011000300001 · Cited by 125
Chen, D.-L., Wang, Z.-Q., Zeng, Z.-L., Wu, W.-J., Zhang, D.-S., Luo, H., Wang, F., Qiu, M., Wang, D., Ren, C., et al. (2014) · Hepatology · doi:10.1002/hep.27118 · Cited by 125
Filkowski, J. N., Ilnytskyy, Y., Tamminga, J., Koturbash, I., Golubov, A., Bagnyukova, T., Pogribny, I. P., & Kovalchuk, O. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp300 · Cited by 125
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
Visone, R., Veronese, A., Rassenti, L. Z., Balatti, V., Pearl, D. K., Acunzo, M., Volinia, S., Taccioli, C., Kipps, T. J., & Croce, C. M. (2011) · Blood · doi:10.1182/blood-2011-01-333484 · Cited by 124
Liu, X., Chen, Q., Yan, J. Y., Wang, Y., Zhu, C., Chen, C., Zhao, X., Xu, M., Sun, Q., Deng, R., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.458 · Cited by 124
Biological Activity and Biotechnological Aspects of Locked Nucleic Acids
Lundin, K. E., Højland, T., Hansen, B. R., Persson, R., Bramsen, J. B., Kjems, J., Koch, T., Wengel, J., & Smith, C. I. E. (2013) · Advances in genetics · doi:10.1016/b978-0-12-407676-1.00002-0 · Cited by 123
Ng, W. L., Yan, D., Zhang, X., Mo, Y., & Wang, Y. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.08.007 · Cited by 123
Yau, T. O., Wu, C. W., Dong, Y., Tang, C.-M., Ng, S. S. M., Chan, F. K. L., Sung, J. J. �., & Yu, J. Q. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.484 · Cited by 123
Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma
Babae, N., Bourajjaj, M., Liu, Y., van Beijnum, J. V., Cerisoli, F., Scaria, P., Verheul, M., van Berkel, M., Pieters, E. H. E., van Haastert, R. J., et al. (2014) · OncoTarget · doi:10.18632/oncotarget.2235 · Cited by 122
Ward, A., Shukla, K., Balwierz, A., Soons, Z. I. T. A., König, R., Şahin, Ö., & Wiemann, S. (2014) · The Journal of Pathology · doi:10.1002/path.4363 · Cited by 121
Rather, M. I., Nagashri, M. N., Swamy, S. S., Gopinath, K. S., & Kumar, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.425736 · Cited by 121
Rothschild, S. I. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-7 · Cited by 120
miR-221/222: promising biomarkers for breast cancer
Chen, W., Hu, Q., Qiu, M., Zhong, S., Xu, J., Tang, J., & Zhao, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0750-y · Cited by 119
Kroiss, A., Vincent, S., Decaussin‐Petrucci, M., Meugnier, E., Viallet, J. P., Ruffion, A., Chalmel, F., Samarut, J., & Allioli, N. (2014) · Oncogene · doi:10.1038/onc.2014.222 · Cited by 118
Luo, W., Huang, B., Li, Z., Li, H., Sun, L., Zhang, Q., Qiu, X., & Wang, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064759 · Cited by 118
Chen, D., Dang, B., Huang, J., Chen, M., Wu, D., Xu, M., Li, R., & Yan, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4702 · Cited by 117
Du, C., Lv, Z., Cao, L., Ding, C., Owusu-Ansah, K. G., Xie, H., Zhou, L., Wu, J., & Zheng, S. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0259-1 · Cited by 117
MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1
Wu, Q., Yang, Z., An, Y., Hu, H., Yin, J., Zhang, P., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.110 · Cited by 116
MiR-204 is responsible for inherited retinal dystrophy associated with ocular coloboma
Conte, I., Hadfield, K. D., Barbato, S., Carrella, S., Pizzo, M., Bhat, R. S., Carissimo, A., Karali, M., Porter, L. F., Urquhart, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401464112 · Cited by 115
Yang, Y., Li, F., Saha, M. N., Abdi, J., Qiu, L., & Chang, H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1437 · Cited by 115
Tan, S. H., Li, R. Q., Ding, K., Lobie, P. E., & Zhu, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.042 · Cited by 114
Generation of miRNA sponge constructs
Kluiver, J. L., Ślęzak-Prochazka, I., Smigielska‐Czepiel, K., Halsema, N., Kroesen, B., & van den Berg, A. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.019 · Cited by 113
Epigenetic control of epithelial-mesenchymal-transition in human cancer
Kiesslich, T., Pichler, M., & Neureiter, D. (2012) · Molecular and Clinical Oncology · doi:10.3892/mco.2012.28 · Cited by 111
Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer
Zhang, Y., Wang, X., Xu, B., Wang, B., Wang, Z., Liang, Y., Zhou, J., Hu, J., & Jiang, B. (2013) · Oncology Reports · doi:10.3892/or.2013.2633 · Cited by 111
MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells
Du, B., Wang, Z., Zhang, X., Feng, S., Wang, G., He, J., & Zhang, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088022 · Cited by 107
Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth
Tang, H., Liu, X., Wang, Z., She, X., Zeng, X., Deng, M., Liao, Q., Guo, X., Wang, R., Li, X., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.034 · Cited by 102
Zhao, Y., Zhao, L., Ischenko, I., Bao, Q., Schwarz, B., Nieß, H., Wang, Y., Renner, A., Mysliwietz, J., Jauch, K., et al. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0360-2 · Cited by 101
Zaravinos, A., Radojicic, J., Lambrou, G. Ι., Volanis, D., Delakas, D., Stathopoulos, E. N., & Spandidos, D. A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.03.122 · Cited by 100
Self-citationZoni, E., van der Horst, G., van de Merbel, A. F., Chen, L., Rane, J. K., Pelger, R. C. M., Collins, A. T., Visakorpi, T., Snaar-Jagalska, E. B., Maitland, N. J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2155 · Cited by 100
MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
Sachdeva, M., Mito, J. K., Lee, C., Zhang, M., Li, Z., Dodd, R. D., Cason, D., Luo, L., Ma, Y., Mater, D. V., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77116 · Cited by 99
MiR-20a Promotes Cervical Cancer Proliferation and Metastasis In Vitro and In Vivo
Zhao, S., Yao, D., Chen, J., Ding, N., & Ren, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120905 · Cited by 98
miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells
Humphreys, K. J., McKinnon, R. A., & Michael, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112288 · Cited by 98
Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells
Bezzerri, V., Borgatti, M., Finotti, A., Tamanini, A., Gambari, R., & Cabrini, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100821 · Cited by 98
Self-citationZhou, X., Hu, Y., Dai, L., Wang, Y., Zhou, J., Wang, W., Di, W. J., & Qiu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096718 · Cited by 96
Sossey‐Alaoui, K., Downs-Kelly, E. P., Das, M., Izem, L., Tubbs, R., & Plow, E. F. (2010) · International Journal of Cancer · doi:10.1002/ijc.25793 · Cited by 96
Liu, Y., Han, Y., Zhang, H., Nie, L., Jiang, Z., Fa, P., Gui, Y., & Cai, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052280 · Cited by 96
Fabbri, E., Borgatti, M., Montagner, G., Bianchi, N., Finotti, A., Lampronti, I., Bezzerri, V., Dechecchi, M. C., Cabrini, G., & Gambari, R. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0160oc · Cited by 94
Self-citationMiR ‐383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 ( PRDX3 )
Li, K. K., Pang, J. C., Lau, K., Zhou, L., Mao, Y. Q., Wang, Y., Poon, W. S., & Ng, H. (2012) · Brain Pathology · doi:10.1111/bpa.12014 · Cited by 93
Epithelial stem cell mutations that promote squamous cell carcinoma metastasis
White, R. A., Neiman, J. M., Reddi, A. H., Han, G., Birlea, S. A., Mitra, D., Dionne, L., Fernandez, P., Murao, K., Bian, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65856 · Cited by 90
miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a
Hu, W., Dooley, J., Chung, S. S., Chandramohan, D., Cimmino, L., Mukherjee, S., Mason, C. E., Strooper, B. D., Liston, A., & Park, C. Y. (2015) · Blood · doi:10.1182/blood-2014-06-585273 · Cited by 90
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Glover, A. R., Zhao, J., Gill, A. J., Weiss, J., Amaro-Mugridge, N. B., Kim, E., Feeney, A. L., Ip, J. C. Y., Reid, G., Clarke, S. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5383 · Cited by 88
Prediction of Associations between microRNAs and Gene Expression in Glioma Biology
Wuchty, S., Arjona, D., Li, A., Kotliarov, Y., Walling, J., Ahn, S. J., Zhang, A., Maric, D., Anolik, R., Zenklusen, J. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014681 · Cited by 88
XU, J., Zhang, W., Lv, Q., & Zhu, D. (2015) · Oncology Reports · doi:10.3892/or.2015.3931 · Cited by 88
Lee, S. H., Jung, Y. D., Choi, Y. S., & Lee, Y. M. (2015) · Oncotarget · doi:10.18632/oncotarget.5037 · Cited by 88
microRNA: Diagnostic Perspective
Faruq, O., & Vecchione, A. M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00051 · Cited by 86
miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1
Chen, Z., Liu, S., Li, T. X., Wu, M., Ai, F., Tang, W., Zhao, L., Ding, J., Zhang, L., & Tang, A. (2015) · Oncotarget · doi:10.18632/oncotarget.5709 · Cited by 86
miR-206 Represses Hypertrophy of Myogenic Cells but Not Muscle Fibers via Inhibition of HDAC4
Winbanks, C. E., Beyer, C., Hagg, A., Qian, H., Sepulveda, P. V., & Gregorevic, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073589 · Cited by 85
Exosomic microRNAs in the Tumor Microenvironment
Neviani, P., & Fabbri, M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00047 · Cited by 81
Wang, X., Wu, Q., Xu, B., Wang, P., Fan, W., Cai, Y., Gu, X., & Meng, F. (2015) · FEBS Journal · doi:10.1111/febs.13502 · Cited by 81
Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
Kwekkeboom, R. F. J., Lei, Z., Doevendans, P. A., Musters, R. J. P., & Sluijter, J. P. G. (2014) · Clinical Science · doi:10.1042/cs20140005 · Cited by 81
Siu, M. K., Tsai, Y.-C., Chang, Y.-S., Yin, J., Suau, F., Chen, W.-Y., & Liu, Y.-N. (2014) · Oncogene · doi:10.1038/onc.2014.414 · Cited by 81
Costa, P. M., Cardoso, A. L., Nóbrega, C., Pereira de Almeida, L. F., Bruce, J. N., Canoll, P., & Pedroso de Lima, M. C. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds496 · Cited by 80
Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma
Zhang, R., Pang, B., Xin, T., Guo, H., Xing, Y., Xu, S., Feng, B., Liu, B., & Pang, Q. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9079-9 · Cited by 80
Modulation of the Biological Activity of microRNA‐210 with Peptide Nucleic Acids (PNAs)
Fabbri, E., Manicardi, A., Tedeschi, T., Sforza, S., Bianchi, N., Brognara, E., Finotti, A., Breveglieri, G., Borgatti, M., Corradini, R., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100270 · Cited by 80
Self-citationNF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10
Sun, Y., Ai, X., Shen, S., & Lü, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3135 · Cited by 79
Huang, T., Chang, H., Chen, C., Wu, P., Lee, H., Liao, Y., Hsu, W., Huang, H., & Juan, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.025 · Cited by 77
Zhang, Q., Ran, R., Zhang, L., Liu, Y., Mei, L., Zhang, Z., Gao, H., & He, Q. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.010 · Cited by 77
Leivonen, S., Rokka, A., Östling, P., Kohonen, P. J., Corthals, G. L., Kallioniemi, O., & Perälä, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.005322 · Cited by 77
Haug, B. H., Henriksen, J. R., Buechner, J., Geerts, D., Tømte, E., Kogner, P., Martinsson, T., Flægstad, T., Sveinbjørnsson, B., & Einvik, C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr073 · Cited by 77
MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma
Ni, F., Zhao, H., Cui, H., Wu, Z., Chen, L., Hu, Z., Guo, C., Liu, Y., Chen, Z., Wang, X., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.041 · Cited by 76
IL-8 is a mediator of NF-κB induced invasion by gliomas
Raychaudhuri, B., & Vogelbaum, M. A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0261-2 · Cited by 76
Gao, H., Teng, C.-Y., Huang, W., Peng, J.-J., & Wang, C.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921643 · Cited by 76
microRNA-34a as a Therapeutic Agent against Human Cancer
Saito, Y., Nakaoka, T., & Saito, H. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4111951 · Cited by 76
miR149 functions as a tumor suppressor by controlling breast epithelial cell migration and invasion.
Bischoff, A., Huck, B., Keller, B., Strotbek, M., Schmid, S., Boerries, M., Busch, H., Müller, D., & Olayioye, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3319 · Cited by 75
Wagenaar, T. R., Zabludoff, S., Ahn, S., Allerson, C. R., Arlt, H., Baffa, R., Cao, H., Davis, S. P., García-Echeverría, C., Gaur, R., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0703 · Cited by 75
MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang, C., Yuan, P., & Li, Y. (2015) · Europe PMC (PubMed Central) · Cited by 73
Zhao, Z., Ma, X., Sung, D. C., Li, M., Kosti, A., Lin, G. E., Chen, Y., Pertsemlidis, A., Hsiao, T.-H., & Du, L. (2015) · RNA Biology · doi:10.1080/15476286.2015.1023495 · Cited by 73
Brognara, E., Fabbri, E., Aimi, F., Manicardi, A., Bianchi, N., Finotti, A., Breveglieri, G., Borgatti, M., Corradini, R., Marchelli, R., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1632 · Cited by 72
Self-citationXia, Z., Liu, F., Zhang, J., & Liu, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132399 · Cited by 71
Cancer therapy via modulation of micro RNA levels: a promising future.
Kota, S. K., & Balasubramanian, S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.07.003 · Cited by 71
Snail-Regulated MiR-375 Inhibits Migration and Invasion of Gastric Cancer Cells by Targeting JAK2
Xu, Y., Jin, J. F., Liu, Y., Zhenxia, H., Deng, Y., You, T., Zhou, T., Si, J., & Zhuo, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099516 · Cited by 71
miR‐493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver
Okamoto, K., Ishiguro, T., Midorikawa, Y., Ohata, H., Izumiya, M., Tsuchiya, N., Sato, A., Sakai, H., & Nakagama, H. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.25 · Cited by 71
Qian, X., Ren, Y., Shi, Z., Long, L., Pu, P., Sheng, J., Yuan, X., & Kang, C. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002039 · Cited by 70
Huang, P., Ye, B., Yu, Y., Shi, J., & Zhao, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2972-z · Cited by 69
miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells
Lee, Y.-M., Lee, J.-Y., Ho, C., Hong, Q.-S., Yu, S., Tzeng, C., Yang, P., & Chen, H. (2011) · Breast Cancer Research · doi:10.1186/bcr3059 · Cited by 69
Inflammation and MiR-21 Pathways Functionally Interact to Downregulate PDCD4 in Colorectal Cancer
Peacock, O., Lee, A. C., Cameron, F., Tarbox, R., Vafadar-Isfahani, N., Tufarelli, C., & Lund, J. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110267 · Cited by 68
Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer
Endo, H., Muramatsu, T., Furuta, M., Uzawa, N., Pimkhaokham, A., Amagasa, T., Inazawa, J., & Kozaki, K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs376 · Cited by 68
Brognara, E., Fabbri, E., Montagner, G., Gasparello, J., Manicardi, A., Corradini, R., Bianchi, N., Finotti, A., Breveglieri, G., Borgatti, M., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3308 · Cited by 67
Self-citationGAO, C., Peng, F., & PENG, L. K. (2014) · Neoplasma · doi:10.4149/neo_2014_083 · Cited by 67
MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway
Xia, X., Li, Y., Wang, W., Tang, F., Tan, J., Sun, L., Li, Q., Sun, L., Tang, B., & He, S. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0423-0 · Cited by 66
Magge, S. N., Malik, S. Z., Royo, N. C., Chen, H. I., Yu, L., Snyder, E. Y., O’Rourke, D. M., & Watson, D. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21983 · Cited by 65
Brognara, E., Fabbri, E., Bazzoli, E., Montagner, G., Ghimenton, C., Eccher, A., Cantù, C., Manicardi, A., Bianchi, N., Finotti, A., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1405-6 · Cited by 64
Self-citationThe roles of microRNAs in the regulation of tumor metastasis
Zhou, L., Liu, F., Wang, X., & Ouyang, G. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0028-8 · Cited by 63
Regulation of Lung Cancer Metastasis by Klf4-Numb–like Signaling
Vaira, V., Faversani, A., Martin, N., Garlick, D. S., Ferrero, S., Nosotti, M., Kissil, J. L., Bòsari, S., & Altieri, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4232 · Cited by 63
STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells
Cheng, Y., Li, Y., Nian, Y., Liu, D., Dai, F., & Zhang, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1303-0 · Cited by 62
miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer
Zhang, W., Zhang, J., Wu, X., Yan, T., & Lv, W. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3076 · Cited by 62
MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ
Scheibner, K. A., Teaboldt, B., Hauer, M. C., Chen, X., Cherukuri, S., Guo, Y., Kelley, S. M., Liu, Z., Baer, M. R., Heimfeld, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050895 · Cited by 62
MiR-155 at the heart of oncogenic pathways
Czyzyk-Krzeska, M., & Zhang, X. (2013) · Oncogene · doi:10.1038/onc.2013.26 · Cited by 61
Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment
Hershkovitz‐Rokah, O., Modai, S., Pasmanik, M., Toren, A., Shomron, N., Raanani, P., Shpilberg, O., & Granot, G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.031 · Cited by 61
Clinicopathologic significance of miR-10b expression in gastric carcinoma
Wang, Y., Ye, Z., Zhao, Z., Li, L., Wang, Y., Tao, H., Wang, H., & He, X. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.10.014 · Cited by 61
TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1
Qiu, Y., Luo, X., Kan, T., Zhang, Y., Yu, W., Wei, Y., Shen, N., Yi, B., & Jiang, X. (2013) · Molecular BioSystems · doi:10.1039/c3mb70479c · Cited by 61
Ren, L.-H., Chen, W.-X., Li, X., He, X., Zhang, Z.-M., Li, M., Cao, R.-S., Hao, B., Zhang, H.-J., Qiu, H.-Q., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.485 · Cited by 60
MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
Liu, R., Liu, X., Zheng, Y., Gu, J., Xiong, S., Jiang, P., Jiang, X., Huang, E., YANG, Y., Ge, D., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.2500 · Cited by 60
Cui, L., Wang, Y., Huang, Y., Yu, H., Huang, Y., Wu, L., & Huang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052310 · Cited by 59
MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer
Wu, X., Liu, T., Fang, O., Dong, W., Zhang, F., Leach, L. J., Hu, X., & Luo, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.6594 · Cited by 58
miR‐545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG‐I
Song, B., Ji, W., Guo, S., Liu, A., Jing, W., Shao, C., Li, G., & Jin, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.10.004 · Cited by 55
A Dicer-miR-107 Interaction Regulates Biogenesis of Specific miRNAs Crucial for Neurogenesis
Ristori, E., Lopez‐Ramirez, M. A., Narayanan, A., Hill-Terán, G., Moro, A., Calvo, C., Thomas, J., & Nicoli, S. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.12.013 · Cited by 55
MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met
Wang, L., Yang, N., Su, B., Mu, X., Shen, H., & Du, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1767 · Cited by 55
Wang, W., DAI, L. X., ZHANG, S., Yu, Y., YAN, N., FAN, P., DAI, L., Tian, H. W., Cheng, L., Zhang, X., et al. (2013) · Neoplasma · doi:10.4149/neo_2013_036 · Cited by 55
Xiong, Y., Kotian, S., Zeiger, M. A., Zhang, L., & Kebebew, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130496 · Cited by 54
Gomes, S. E., Simões, A. E. S., Pereira, D. M., Castro, R. E., Rodrigues, C. M. P., & Borralho, P. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7010 · Cited by 54
Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells
Lambertini, E., Lolli, A., Vezzali, F., Penolazzi, L., Gambari, R., & Piva, R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-445 · Cited by 53
Self-citationAskou, A. L., Aagaard, L., Kostic, C., Arsenijévic, Y., Hollensen, A. K., Bek, T., Jensen, T. G., Mikkelsen, J. G., & Corydon, T. J. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.64 · Cited by 53
Sun, S., Wang, Q., Giang, A., Cheng, C., Soo, C. B., Wang, C., Liau, L. M., & Chiu, R. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0220-y · Cited by 52
AntagomiR-27a Targets FOXO3a in Glioblastoma and Suppresses U87 Cell Growth in Vitro and in Vivo
Ge, Y.-F., Sun, J., Jin, C.-J., Cao, B.-Q., Jiang, Z., & Shao, J.-F. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.963 · Cited by 51
YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research
Cheng, W., Chung, I., Tsai, C.-F., Huang, T.-S., Chen, C., Wang, S., Chang, T., Sun, H.-J., Chao, J. Y. C., Cheng, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1156 · Cited by 50
Kikkawa, N., Kinoshita, T., Nohata, N., Hanazawa, T., Yamamoto, N., FUKUMOTO, I., Chiyomaru, T., Enokida, H., Nakagawa, M., Okamoto, Y., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2349 · Cited by 50
Managing MicroRNAs with Vector-Encoded Decoy-Type Inhibitors
Bak, R. O., Hollensen, A. K., & Mikkelsen, J. G. (2013) · Molecular Therapy · doi:10.1038/mt.2013.113 · Cited by 49
miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4
Cai, J., Qi, Z., Chen, L., Yao, Y., Gong, Y. Q., & Mao, Y. Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4355 · Cited by 49
Involvement of nuclear factor‐kappa B in bcl‐xL‐induced interleukin 8 expression in glioblastoma
Gabellini, C., Castellini, L., Trisciuoglio, D., Kracht, M., Zupi, G., & Bufalo, D. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05661.x · Cited by 48
Long, H., Wang, Z., Chen, J., Xiang, T., Li, Q., Diao, X., & Zhu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.5478 · Cited by 48
Dong, L., Chen, L., Wang, W., & Zhang, L. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0257-5 · Cited by 47
The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity
Chen, S.-M., Chou, W., Hu, L., Hsiung, C.-N., Chu, H., Huang, Y.-L., Hsu, H.-M., Yu, J.-C., & Shen, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128472 · Cited by 47
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells
Fabbri, E., Montagner, G., Bianchi, N., Finotti, A., Borgatti, M., Lampronti, I., Cabrini, G., & Gambari, R. (2016) · Oncology Reports · doi:10.3892/or.2016.4676 · Cited by 47
Self-citationLiu, X., Liu, Z.-J., He, H., Zhang, C., & Wang, Y.-L. (2015) · Europe PMC (PubMed Central) · Cited by 43
Data Submission and Quality in Microarray-Based MicroRNA Profiling
Witwer, K. W. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.193813 · Cited by 42
Giunti, L., Ros, M. D., Vinci, S., Gelmini, S., Iorio, A. L., Buccoliero, A. M., Cardellicchio, S., Castiglione, F., Genitori, L., de Martino, M., et al. (2015) · Europe PMC (PubMed Central) · Cited by 41
MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cells
Knackmuss, U., Lindner, S. E., Aneichyk, T., Kotkamp, B., Knust, Z., Villunger, A., & Herzog, S. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.87 · Cited by 41
miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma
Long, Q., Du, Y., Liu, X., Li, X., & He, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3369-3 · Cited by 41
UCbase & miRfunc: a database of ultraconserved sequences and microRNA function
Taccioli, C., Fabbri, E., Visone, R., Volinia, S., Calin, G. A., Fong, L. Y. Y., Gambari, R., Bottoni, A., Acunzo, M., Hagan, J. P., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn702 · Cited by 41
Self-citationThe molecular mechanisms and therapeutic potential of microRNA-7 in cancer
Gu, D.-N., Huang, Q., & Tian, L. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.988708 · Cited by 41
Role of MicroRNAs-221/222 in Digestive Systems
Matsuzaki, J., & Suzuki, H. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4081566 · Cited by 41
MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
Wang, Y., Wang, X., Zhang, J., Sun, G., Luo, H., Kang, C., Pu, P., Jiang, T., Liu, N., & You, Y. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0679-1 · Cited by 41
Chen, Q., Jiao, D., Li, Y., Wu, Y.-Q., Hu, H., Song, J., Yan, J., Wu, L., Xu, L., & Shi, J. (2015) · Molecular BioSystems · doi:10.1039/c4mb00734d · Cited by 40
TRIM27/MRTF-B-Dependent Integrin β1 Expression Defines Leading Cells in Cancer Cell Collectives
Kato, T., Enomoto, A., Watanabe, T., Haga, H., Ishida‐Ishihara, S., Kondo, Y., Furukawa, K., Urano, T., Mii, S., Weng, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.068 · Cited by 40
Zhang, S., Han, L., WEI, J., Shi, Z., Pu, P., Zhang, J., Yuan, X., & Kang, C. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2841 · Cited by 39
Role of miR-155 in breast cancer
Wang, J., & Wu, J. (2012) · Frontiers in bioscience · doi:10.2741/4056 · Cited by 38
Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery
Avitabile, C., Accardo, A., Ringhieri, P., Morelli, G., Saviano, M., Montagner, G., Fabbri, E., Gallerani, E., Gambari, R., & Romanelli, A. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00156 · Cited by 38
Self-citationRegulation of IL-8 gene expression in gliomas by microRNA miR-93
Fabbri, E., Brognara, E., Montagner, G., Ghimenton, C., Eccher, A., Cantù, C., Khalil, S., Bezzerri, V., Provezza, L., Bianchi, N., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1659-1 · Cited by 36
Self-citationmiR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9
Jiang, L., Ai-yong, H., Zhang, Q., & Cheng, T. (2014) · Tumor Biology · doi:10.1007/s13277-014-2588-3 · Cited by 36
MicroRNAs as newer therapeutic targets: A big hope from a tiny player
Ghelani, H., Rachchh, M., & Gokani, R. (2012) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.99416 · Cited by 35
Zhang, Y., Li, H., Han, J., & Zhang, Y. (2015) · Europe PMC (PubMed Central) · Cited by 34
microRNA-25 promotes osteosarcoma cell proliferation by targeting the cell-cycle inhibitor p27
WANG, X.-H., Cai, P., Wang, M., & Wang, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2260 · Cited by 33
Bianchi, N., Finotti, A., Ferracin, M., Lampronti, I., Zuccato, C., Breveglieri, G., Brognara, E., Fabbri, E., Borgatti, M., Negrini, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121567 · Cited by 32
Self-citationBachetti, T., Zanni, E. D., Ravazzolo, R., & Ceccherini, I. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.008 · Cited by 31
Lu, S., Jiang, X., Xiao, G., Liu, D.-Y., & Yuan, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3455 · Cited by 31
Analysis of miR-221 and p27 expression in human gliomas
You (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000152 · Cited by 31
Spatiotemporal dynamics of microRNA during epithelial collective cell migration
Dean, Z., Riahi, R., & Wong, P. K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.022 · Cited by 30
Maia, B. D. M., Ling, H. Y., Monroig-Bosque, P. D. C., Ciccone, M., Soares, F. A., Călin, G. A., & Rocha, R. M. (2015) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2015.08.002 · Cited by 27
Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR.
Chabot, S., Teissié, J., & Golzio, M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.002 · Cited by 27
Staedel, C., Varon, C., Nguyen, P. H., Vialet, B., Chambonnier, L., Rousseau, B., Soubeyran, I., Évrard, S., Couillaud, F., & Darfeuille, F. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.18 · Cited by 26
Hou, C., Sun, B., Jiang, Y. X., Zheng, J., Yang, N., Ji, C., Liang, Z., Shi, J., Zhang, R., Liu, Y., et al. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150824152353 · Cited by 25
Murakami, K., & Miyagishi, M. (2014) · Biomedical Reports · doi:10.3892/br.2014.260 · Cited by 22
Functional Analysis of miR-34c as a Putative Tumor Suppressor in High-Grade Serous Ovarian Cancer1
Yu, Z., Kim, J., He, L., Creighton, C. J., Gunaratne, P. H., Hawkins, S. M., & Matzuk, M. M. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121988 · Cited by 22
Li, L., & Wang, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151119729 · Cited by 20
Morris, J. K., Chomyk, A. M., Song, P., Parker, N., Deckard, S. A., Trapp, B. D., Pimplikar, S. W., & Dutta, R. (2015) · Invertebrate Neuroscience · doi:10.1007/s10158-015-0180-1 · Cited by 17
Liu, G., Liu, Y., Yang, Z., Wang, J., LI, D., & Zhang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4335 · Cited by 17
Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors
Shalaby, T., Fiaschetti, G., Baumgartner, M., & Grotzer, M. A. (2014) · Molecules · doi:10.3390/molecules19055821 · Cited by 17
Therapeutic Potential of microRNAs
Ivković, T. C., & Călin, G. A. (2015) · CRC Press eBooks · doi:10.1201/b18002-26 · Cited by 17
Differential Masking of Natural Genetic Variation by miR-9a inDrosophila
Cassidy, J. J., Straughan, A. J., & Carthew, R. W. (2015) · Genetics · doi:10.1534/genetics.115.183822 · Cited by 16
Cited by
Recent Advances in miRNA Delivery Systems
Dasgupta, I., & Chatterjee, A. (2021) · Methods and Protocols · doi:10.3390/mps4010010 · Cited by 307
RNAi therapeutic and its innovative biotechnological evolution
Weng, Y., Xiao, H., Zhang, J., Liang, X.-J., & Huang, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.012 · Cited by 286
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
Pomatto, M. A. C., Bussolati, B., D’Antico, S., Ghiotto, S., Tetta, C., Brizzi, M. F., & Camussi, G. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.001 · Cited by 243
Interplay between miRNAs and host genes and their role in cancer
Liu, B., Shyr, Y., Cai, J., & Liu, Q. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz002 · Cited by 137
MicroRNA as an Important Target for Anticancer Drug Development
Fu, Z., Wang, L., Li, S., Chen, F., Au-Yeung, K. K.-W., & Shi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736323 · Cited by 133
Metadata
- Authors
- GAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2016-05-04
- Volume
- 49
- Issue
- 1
- Pages
- 5-32
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2345940501
- Cited by
- 262
- References
- 359
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.